Navigation Links
Better Research Rats To Help In Learning About Hypertension

Scientists have bred a new kind of rat that will help them to study the effects of lower levels of estrogen in postmenopausal women that can lead to hypertension and heart failure.

Researchers at Wake Forest University School of Medicine // have created a better research rat by changing a single gene that is involved in hypertension. These rats will allow them to study salt-sensitivity in hypertension as well as explore how estrogen depletion affects several body systems.

The researchers are presenting three reports on their research at the American Heart Association’s 59th Annual Fall Conference and Scientific Sessions of the Council for High Blood Pressure Research in Washington, D.C.

In the study the team had looked at how estrogen depletion affects diastolic heart dysfunction. In this common form of heart failure, the heart muscle becomes stiff and cannot fill with enough blood to meet the body’s demands. Diastolic dysfunction is more common in women after menopause and is frequently associated with hypertension.

In these rats, the researchers found that estrogen depletion exacerbates the progression of diastolic dysfunction. Scientists have long known that estrogen helps protect heart vessels from atherosclerosis, the buildup of fatty deposits that can cause heart attacks. This research suggests that it may also protect heart function.

The researchers had tried to determine if estrogen is also protective against the hypertension and renal damage that arises from excess salt in the diet. In the rats fed a high salt diet, estrogen depletion increased blood pressure and exacerbated renal injury. The lack of estrogen resulted in increase levels of a hormone called aldosterone that may contribute to both diastolic dysfunction and kidney injury.

Source: Newswise
'"/>




Page: 1

Related medicine news :

1. Better prostate cancer detection
2. Better Treatment for obesity
3. For a Better Memory
4. Baby Talk Better Than Adult Speech
5. Drug Combo Works Better for children with ADHD, Tics
6. Better skin with lasers
7. Better diabetes treatment promises Vanadium
8. Better Prostate Cancer Test
9. Better Drug for Heart Transplant
10. Better Diet Even Late in Life May Prolong It
11. Better Care Required for Breast Cancer Survivors
Post Your Comments:
(Date:7/25/2008)... DALLAS, July 25 /PRNewswire/ -- BeaconEquity.c...tocks making news today., Investors can view all ...http://BeaconEquity.com/m , Today,s Trade Alerts ...),MiddleBrook Pharmaceuticals Inc. (Nasdaq: MBRK...daq: ADLR ), Affymetrix Inc. (Nasdaq: AFFX ) and...
(Date:7/25/2008)... Expanded Relationship Based on Significant Improv...wswire/ -- MDdatacor, Inc., a leader in health,car...d providers, today,announced it has entered into a...ue to support Wellmark,s Collaboration on Quality(... collaboration between Wellmark and,primary care c...
(Date:7/25/2008)... CARLSBAD, Calif., July 25 /PRNewswire/ -- Auto... registration statement on Form S-1 with the,Secur...osed initial public,offering of shares of its comm...be offered, all of which are expected to be offere...he offering, have not yet been,determined., J.P. ...
(Date:7/25/2008)... Whether you are an Olymp...d Warrior, there are Five Things You Need to Know ...the D.I.S.C. Spine and Sports Center , ...25, 2008 -- America,s premier athletes are heading...onditioning and sacrifice in the hopes of capturin...
Breaking Medicine News(10 mins):Health News:BeaconEquity.com Issues Technical Trade Alerts on Healthcare/Pharmaceutical Stocks: DUSA, MBRK, NOVA, ADLR, AFFX, ABAX 2Health News:BeaconEquity.com Issues Technical Trade Alerts on Healthcare/Pharmaceutical Stocks: DUSA, MBRK, NOVA, ADLR, AFFX, ABAX 3Health News:MDdatacor Extends Contract with Wellmark, Inc. 2Health News:MDdatacor Extends Contract with Wellmark, Inc. 3Health News:AutoGenomics, Inc. Files Registration Statement for Initial Public Offering 2Health News:Hydration Will Be Key For Beijing Bound Olympians, What Every Athlete Must Know 2Health News:Hydration Will Be Key For Beijing Bound Olympians, What Every Athlete Must Know 3Health News:Hydration Will Be Key For Beijing Bound Olympians, What Every Athlete Must Know 4Health News:Hydration Will Be Key For Beijing Bound Olympians, What Every Athlete Must Know 5
...nge name for something even more surprising - a cu...ent, and its Vietnamese advocates say it ends depe...ays. This happens without side effects and without... with the Methadone treatment). If it is really a ...
...eveals for the first time one of the mechanisms by... skin cancer, grows and spreads. This discovery ma...ll arsenal of treatments available for this danger...ew melanoma treatment target in decades. Study pro...
... initiated by World HealthOrganization's (WHO) aut...le official and unofficialsources, soon after any ...o international publichealth. In a crucial decisio... WHO would carry out a through on-the-spotinvestig...
...t of elderly people over age 85 have Alzheimer’s d...mone therapy may cause some postmenopausal women t...with many cognitive disorders, including Alzheimer...ty studied more than 4,500 postmenopausal women wh...
Other Medicine News:Health News:Hope for First New Melanoma Treatment in Decades 2
(Date:7/24/2008)...e-Clinical Data Shows Increased Muscle and Blood V...als, Hearts, SUNRISE, Fla., July 24 /PRNewswire-F...ing the injection of myoblasts modified to express...nto the scar tissue of the,myocardium of rats, whi...presented at two scientific meetings -- the Intern...
(Date:7/24/2008)... New JIT Enrollment Program Speeds Oncology Pat...rmatech, Inc., a Research Management,Organization ...ical,companies to provide research and site manage...Just-in-Time (JIT) enrollment strategy. The new,tr...llicular Non-Hodgkin,s,Lymphoma, Metastatic Breast...
(Date:7/23/2008)... Nexavar is First Approved Systemic Therapy to Tre...if., July 23 /-,Bayer Healt...c. (Nasdaq:,ONXX) today announced that The New Eng...ase 3 trial demonstrating that Nexavar(R) (sorafen...y 31 percent in patients with,unresectable hepatoc...
(Date:7/23/2008)...OSTON, July 23 /- FluoroPharma Inc., ...g agents for the Positron Emission Tomography,(PET...FPET, its novel,Fluorine-18 labeled tracer for myo... second cardiovascular product to complete Phase I...ent, designed to assess the blood flow in the,hear...
Breaking Medicine Technology:Bioheart Reports Promising Results From SDF-1 Modified MyoCell(R) Therapy in Heart Failure Study 2Bioheart Reports Promising Results From SDF-1 Modified MyoCell(R) Therapy in Heart Failure Study 3Bioheart Reports Promising Results From SDF-1 Modified MyoCell(R) Therapy in Heart Failure Study 4Bioheart Reports Promising Results From SDF-1 Modified MyoCell(R) Therapy in Heart Failure Study 5Bioheart Reports Promising Results From SDF-1 Modified MyoCell(R) Therapy in Heart Failure Study 6Pharmatech, Inc. Contracts for Five New Just-in-Time Clinical Trials 2The New England Journal of Medicine Publishes Nexavar(R) Study Demonstrating Significant Improvement in Overall Survival in Patients With Liver Cancer 2The New England Journal of Medicine Publishes Nexavar(R) Study Demonstrating Significant Improvement in Overall Survival in Patients With Liver Cancer 3The New England Journal of Medicine Publishes Nexavar(R) Study Demonstrating Significant Improvement in Overall Survival in Patients With Liver Cancer 4The New England Journal of Medicine Publishes Nexavar(R) Study Demonstrating Significant Improvement in Overall Survival in Patients With Liver Cancer 5The New England Journal of Medicine Publishes Nexavar(R) Study Demonstrating Significant Improvement in Overall Survival in Patients With Liver Cancer 6FluoroPharma Announces Positive Phase I Safety Results for BFPET(TM), Myocardial Perfusion Imaging (MPI) Tracer for Positron Emission Tomography (PET) 2FluoroPharma Announces Positive Phase I Safety Results for BFPET(TM), Myocardial Perfusion Imaging (MPI) Tracer for Positron Emission Tomography (PET) 3Eisai Corporation of North America Announces Appointment of Cynthia Schwalm as President Eisai Inc 5090 1Eisai Corporation of North America Announces Appointment of Cynthia Schwalm as President Eisai Inc 5090 2Volcano Announces Participation in SATURN Clinical Trial Sponsored by AstraZeneca 1966 1Volcano Announces Participation in SATURN Clinical Trial Sponsored by AstraZeneca 1966 2Volcano Announces Participation in SATURN Clinical Trial Sponsored by AstraZeneca 1966 3Anti Clotting Drug as Good as Aspirin at Stopping Second Stroke 18377 1Anti Clotting Drug as Good as Aspirin at Stopping Second Stroke 18377 2BRCA Mutations Dont Spot All High Risk Women 18375 1BRCA Mutations Dont Spot All High Risk Women 18375 2BRCA Mutations Dont Spot All High Risk Women 18375 3
...tudy Results Presented at Society of Nuclear,Medic...RNewswire-FirstCall/ --,Immunomedics, Inc. , a bio...lonal antibodies to treat cancer and other serious...bryonic antigen,(CEA) antibody, labetuzumab, label... be safe and active when given in two doses,to pat...
...IRE)--Jun 4, 2007 - Pfizer announced today that,ax...tive inhibitor,of VEGFR 1, 2,3 (vascular endotheli...gemcitabine showed a trend towards prolonged,overa...tic cancer,compared with gemcitabine alone, accor...I trial., These data were presented at the 43rd Am...
Other Medicine Technology:Repeated Radioimmunotherapy With 131I-Labetuzumab Appears Safe and,Effective in Colorectal Cancer with Liver Metastases 2Repeated Radioimmunotherapy With 131I-Labetuzumab Appears Safe and,Effective in Colorectal Cancer with Liver Metastases 3Repeated Radioimmunotherapy With 131I-Labetuzumab Appears Safe and,Effective in Colorectal Cancer with Liver Metastases 4Repeated Radioimmunotherapy With 131I-Labetuzumab Appears Safe and,Effective in Colorectal Cancer with Liver Metastases 5New Data Show Pfizer's Axitinib Prolonged Overall Survival in,Advanced Pancreatic Cancer When Combined with Standard of Care,Chemotherapy 2New Data Show Pfizer's Axitinib Prolonged Overall Survival in,Advanced Pancreatic Cancer When Combined with Standard of Care,Chemotherapy 3New Data Show Pfizer's Axitinib Prolonged Overall Survival in,Advanced Pancreatic Cancer When Combined with Standard of Care,Chemotherapy 4
...UP Laboratories is a national reference laboratory...esearch and development. ARUP offers an extensive ...ts in clinical and anatomic pathology. Owned by th...nclude more than half of the nation's university t...
...UP Laboratories is a national reference laboratory...esearch and development. ARUP offers an extensive ...ts in clinical and anatomic pathology. Owned by th...nclude more than half of the nation's university t...
...UP Laboratories is a national reference laboratory...esearch and development. ARUP offers an extensive ...ts in clinical and anatomic pathology. Owned by th...nclude more than half of the nation's university t...
...UP Laboratories is a national reference laboratory...esearch and development. ARUP offers an extensive ...ts in clinical and anatomic pathology. Owned by th...nclude more than half of the nation's university t...
Medicine Products: